Northern Trust Corp Kaleido Biosciences, Inc. Transaction History

Northern Trust Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.05 - $1.7 $10,191 - $346,516	-203,833 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.3 - $2.7 $16,810 - $34,913	-12,931 Reduced 5.97%	203,833 $336,000
Q4 2021 Feb 08, 2022	SELL	$2.39 - $6.02 $13,135 - $33,085	-5,496 Reduced 2.47%	216,764 $519,000
Q3 2021 Nov 15, 2021	BUY	$5.36 - $7.99 $67,986 - $101,345	12,684 Added 6.05%	222,260 $1.21 Million
Q2 2021 Aug 13, 2021	BUY	$5.82 - $8.72 $45,634 - $68,373	7,841 Added 3.89%	209,576 $1.56 Million
Q1 2021 May 12, 2021	SELL	$7.2 - $16.82 $3,672 - $8,578	-510 Reduced 0.25%	201,735 $1.64 Million
Q4 2020 Feb 11, 2021	BUY	$5.77 - $11.33 $2,890 - $5,676	501 Added 0.25%	202,245 $1.84 Million
Q3 2020 Nov 16, 2020	BUY	$5.09 - $11.07 $54,529 - $118,592	10,713 Added 5.61%	201,744 $2.23 Million
Q2 2020 Aug 14, 2020	BUY	$4.62 - $8.01 $294,358 - $510,349	63,714 Added 50.04%	191,031 $1.42 Million
Q1 2020 May 14, 2020	BUY	$3.62 - $9.49 $16,699 - $43,777	4,613 Added 3.76%	127,317 $783,000
Q4 2019 Feb 14, 2020	BUY	$5.02 - $8.87 $253,826 - $448,493	50,563 Added 70.09%	122,704 $616,000
Q3 2019 Nov 13, 2019	BUY	$6.74 - $11.3 $402,081 - $674,112	59,656 Added 477.82%	72,141 $543,000
Q2 2019 Aug 13, 2019	BUY	$11.25 - $18.1 $140,456 - $225,978	12,485 New	12,485 $145,000

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.